Tomasz Brzozowski

Appearances

GERD-INDUCED ALTERATIONS IN HYDROGEN SULFIDE SIGNALING AS THE FUNDAMENTAL MECHANISM OF BARRETT’S ESOPHAGUS PATHOGENESIS
Date
May 9, 2023
BACKGROUND: Barrett’s Esophagus (BE) develops after reflux-mediated injury to distal esophagus and is only known precursor of esophageal adenocarcinoma (EAC), a highly deadly and increasingly prevalent cancer…
Speakers
Edyta Korbut
Mateusz Wierdak
Katarzyna Magierowska
Vincent Janmaat
Dominik Bakalarz
Tomasz Brzozowski
Rhonda Souza
Baylor University Medical Center and Baylor Scott and White Research Institute
Michal Kukla
Ron Smits
Presenter
Marcin Magierowski
CAN HYDROGEN SULPHIDE (H2S) DONORS ACT AS A PROMISING DRUG TO REDUCE THE RISK OF HELICOBACTER PYLORI (HP)-INDUCED GASTRIC CARCINOGENESIS? STUDIES <i>IN VITRO</i> ON HP-INFECTED CANCER-ASSOCIATED FIBROBLASTS
Date
May 6, 2023
BACKGROUND: Immune checkpoint blockade has revolutionized cancer treatment by harnessing the patient’s native anti-tumor T cells, but most colorectal cancers do not respond, for unclear reasons…
Speakers
Gracjana Krzysiek-Maczka
Aneta Targosz
Dawid Wnuk
Urszula Szczyrk
Mateusz Wierdak
Malgorzata Strzalka
Jaroslaw Czyz
Agata Ptak-Belowska
Presenter
Tomasz Brzozowski